LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 86 filers reported holding LOXO ONCOLOGY INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $454,000 | +1.8% | 2,615 | -81.2% | 0.02% | -14.8% |
Q4 2016 | $446,000 | +40.3% | 13,900 | +14.5% | 0.03% | +58.8% |
Q3 2016 | $318,000 | -5.1% | 12,140 | -15.9% | 0.02% | -10.5% |
Q2 2016 | $335,000 | -3.5% | 14,440 | +13.7% | 0.02% | -13.6% |
Q1 2016 | $347,000 | -67.1% | 12,700 | -65.8% | 0.02% | -57.7% |
Q4 2015 | $1,055,000 | – | 37,100 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital LLC | 4,028,920 | $129,409,000 | 30.09% |
Casdin Capital, LLC | 360,000 | $11,561,000 | 9.55% |
DAFNA Capital Management LLC | 139,722 | $4,487,000 | 3.94% |
Opaleye Management Inc. | 125,000 | $4,014,000 | 2.36% |
Eventide Asset Management | 740,000 | $23,765,000 | 1.55% |
Crawford Lake Capital Management, LLC | 52,713 | $1,693,000 | 1.22% |
AWM Investment Company, Inc. | 180,000 | $5,781,000 | 1.13% |
Orbimed Advisors | 1,728,000 | $55,495,000 | 0.71% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 423,276 | $13,594,000 | 0.48% |
EAM Investors, LLC | 111,268 | $3,573,000 | 0.48% |